BRAF and melanoma: MD simulations have been performed [102] for exploring the molecular character of BRAF protein, establishing the differences between the wild-type BRAF and mutant BRAF(V600E) protein to unravel the underlying mechanisms of the inhibitor resistance in malignant melanoma.